408 related articles for article (PubMed ID: 25451903)
1. Quality of life in Danish children and adolescents with type 1 diabetes treated with continuous subcutaneous insulin infusion or multiple daily injections.
Birkebaek NH; Kristensen LJ; Mose AH; Thastum M;
Diabetes Res Clin Pract; 2014 Dec; 106(3):474-80. PubMed ID: 25451903
[TBL] [Abstract][Full Text] [Related]
2. Insulin pump treatment; increasing prevalence, and predictors for better metabolic outcome in Danish children and adolescents with type 1 diabetes.
Olsen B; Johannesen J; Fredheim S; Svensson J;
Pediatr Diabetes; 2015 Jun; 16(4):256-62. PubMed ID: 25082292
[TBL] [Abstract][Full Text] [Related]
3. Continuous subcutaneous insulin infusion versus multiple daily injection regimens in children and young people at diagnosis of type 1 diabetes: pragmatic randomised controlled trial and economic evaluation.
Blair JC; McKay A; Ridyard C; Thornborough K; Bedson E; Peak M; Didi M; Annan F; Gregory JW; Hughes DA; Gamble C;
BMJ; 2019 Apr; 365():l1226. PubMed ID: 30944112
[TBL] [Abstract][Full Text] [Related]
4. Continuous subcutaneous insulin infusion versus multiple daily injections in children and young people at diagnosis of type 1 diabetes: the SCIPI RCT.
Blair J; McKay A; Ridyard C; Thornborough K; Bedson E; Peak M; Didi M; Annan F; Gregory JW; Hughes D; Gamble C
Health Technol Assess; 2018 Aug; 22(42):1-112. PubMed ID: 30109847
[TBL] [Abstract][Full Text] [Related]
5. Benefits of continuous subcutaneous insulin infusion on quality of life.
Lukács A; Kiss-Tóth E; Varga B; Soós A; Takác P; Barkai L
Int J Technol Assess Health Care; 2013 Jan; 29(1):48-52. PubMed ID: 23270655
[TBL] [Abstract][Full Text] [Related]
6. Continuous subcutaneous insulin infusion benefits quality of life in preschool-age children with type 1 diabetes mellitus.
Opipari-Arrigan L; Fredericks EM; Burkhart N; Dale L; Hodge M; Foster C
Pediatr Diabetes; 2007 Dec; 8(6):377-83. PubMed ID: 18036064
[TBL] [Abstract][Full Text] [Related]
7. Health-related quality of life and treatment preferences in adolescents with type 1 diabetes. The VIPKIDS study.
Cherubini V; Gesuita R; Bonfanti R; Franzese A; Frongia AP; Iafusco D; Iannilli A; Lombardo F; Rabbone I; Sabbion A; Salvatoni A; Scaramuzza A; Schiaffini R; Sulli N; Toni S; Tumini S; Mosca A; Carle F;
Acta Diabetol; 2014 Feb; 51(1):43-51. PubMed ID: 23508374
[TBL] [Abstract][Full Text] [Related]
8. [Benefits of continuous subcutaneous insulin infusion in children with type 1 diabetes mellitus].
Hasselmann C; Bonnemaison E; Faure N; Mercat I; Bouillo Pépin-Donat M; Magontier N; Chantepie A; Labarthe F
Arch Pediatr; 2012 Jun; 19(6):593-8. PubMed ID: 22584198
[TBL] [Abstract][Full Text] [Related]
9. Clinical Outcome and Cost-Effectiveness Analysis of CSII Versus MDI in Children and Adolescent With Type 1 Diabetes Mellitus in a Public Health Care System of China.
Hu S; Yang H; Chen Z; Leng X; Li C; Qiao L; Lv W; Li T
Front Endocrinol (Lausanne); 2021; 12():604028. PubMed ID: 33859614
[TBL] [Abstract][Full Text] [Related]
10. Continuous subcutaneous insulin infusion. A new way to lower risk of severe hypoglycemia, improve metabolic control, and enhance coping in adolescents with type 1 diabetes.
Boland EA; Grey M; Oesterle A; Fredrickson L; Tamborlane WV
Diabetes Care; 1999 Nov; 22(11):1779-84. PubMed ID: 10546007
[TBL] [Abstract][Full Text] [Related]
11. Clinical effectiveness and cost-effectiveness of continuous subcutaneous insulin infusion for diabetes: systematic review and economic evaluation.
Cummins E; Royle P; Snaith A; Greene A; Robertson L; McIntyre L; Waugh N
Health Technol Assess; 2010 Feb; 14(11):iii-iv, xi-xvi, 1-181. PubMed ID: 20223123
[TBL] [Abstract][Full Text] [Related]
12. Health-economic comparison of continuous subcutaneous insulin infusion with multiple daily injection for the treatment of Type 1 diabetes in the UK.
Roze S; Valentine WJ; Zakrzewska KE; Palmer AJ
Diabet Med; 2005 Sep; 22(9):1239-45. PubMed ID: 16108855
[TBL] [Abstract][Full Text] [Related]
13. Psychosocial benefits of insulin pump therapy in children with diabetes type 1 and their families: The pumpkin multicenter randomized controlled trial.
Mueller-Godeffroy E; Vonthein R; Ludwig-Seibold C; Heidtmann B; Boettcher C; Kramer M; Hessler N; Hilgard D; Lilienthal E; Ziegler A; Wagner VM;
Pediatr Diabetes; 2018 Dec; 19(8):1471-1480. PubMed ID: 30302877
[TBL] [Abstract][Full Text] [Related]
14. Quality of life and treatment satisfaction in adults with Type 1 diabetes: a comparison between continuous subcutaneous insulin infusion and multiple daily injections.
; Nicolucci A; Maione A; Franciosi M; Amoretti R; Busetto E; Capani F; Bruttomesso D; Di Bartolo P; Girelli A; Leonetti F; Morviducci L; Ponzi P; Vitacolonna E
Diabet Med; 2008 Feb; 25(2):213-20. PubMed ID: 18201210
[TBL] [Abstract][Full Text] [Related]
15. A comparison of multiple daily insulin therapy with continuous subcutaneous insulin infusion therapy in adolescents with type 1 diabetes mellitus: a single-center experience from Turkey.
Abaci A; Atas A; Unuvar T; Demir K; Bober E; Büyükgebiz A
J Pediatr Endocrinol Metab; 2009 Jun; 22(6):539-45. PubMed ID: 19694201
[TBL] [Abstract][Full Text] [Related]
16. Continuous subcutaneous insulin infusion therapy: effects on quality of life.
Scheidegger U; Allemann S; Scheidegger K; Diem P
Swiss Med Wkly; 2007 Aug; 137(33-34):476-82. PubMed ID: 17990132
[TBL] [Abstract][Full Text] [Related]
17. Continuous subcutaneous insulin infusion versus multiple daily injections of insulin: economic comparison in adult and adolescent type 1 diabetes mellitus in Australia.
Cohen N; Minshall ME; Sharon-Nash L; Zakrzewska K; Valentine WJ; Palmer AJ
Pharmacoeconomics; 2007; 25(10):881-97. PubMed ID: 17887808
[TBL] [Abstract][Full Text] [Related]
18. MDI versus CSII in Chinese adults with type 1 diabetes in a real-world situation: based on propensity score matching method.
Yu J; Wang H; Zhu M; Xu J
Health Qual Life Outcomes; 2024 Jun; 22(1):47. PubMed ID: 38872219
[TBL] [Abstract][Full Text] [Related]
19. Long-term benefits of continuous subcutaneous insulin infusion in children with Type 1 diabetes: a 4-year follow-up.
Sulli N; Shashaj B
Diabet Med; 2006 Aug; 23(8):900-6. PubMed ID: 16911629
[TBL] [Abstract][Full Text] [Related]
20. [Satisfaction and quality of life evaluation in patients with type 1 diabetes mellitus treated using continuous subcutaneous insulin infusion compared with multiple daily injections].
Lozano-Serrano M; García-Seco JA; García-Seco F; Lozano-Hernández MC; Seco-Segura ÁM; Moreno-Fernández J; Muñoz-Cazallas PA; Ferreiro-Vicario C; Sánchez-Covisa MA
Enferm Clin; 2013; 23(3):96-102. PubMed ID: 23755944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]